Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19.

Authors:
Zaid Y; Doré É; Dubuc I; Archambault AS; Flamand O and 4 more

Journal:
J Allergy Clin Immunol

Publication Year: 2021

DOI:
10.1016/j.jaci.2021.05.032

PMCID:
PMC8180473

PMID:
34111453

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Allergy Clin Immunol

Abbreviation: J Allergy Clin Immunol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Autoimmunity and immunodeficiency associated with monoallelic LIG4 mutations via haploinsufficiency.
Jauch AJ; Bignucolo O; Seki S and 34 more (2023) - Transparency Score: 3/6
Development of mouse models with restricted HLA-B∗57:01 presentation for the study of flucloxacilli…
Ananthula S; Krishnaveni Sivakumar K; Cardone M and 6 more (2023) - Transparency Score: 3/6
Eosinophils promote effector functions of lung group 2 innate lymphoid cells in allergic airway inf…
LeSuer WE; Kienzl M; Ochkur SI and 7 more (2023) - Transparency Score: 4/6
Inherited and acquired errors of type I interferon immunity govern susceptibility to COVID-19 and m…
Bucciol G; COVID Human Genetic Effort; Meyts I. (2023) - Transparency Score: 3/6
Phospholipid remodeling and its derivatives are associated with COVID-19 severity.
Wei J; Liu X; Xiao W and 13 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure of potential conflicts of interest: The authors declare that they have no relevant conflicts of interest."

Evidence found in paper:

"Supported by the Cheikh Zaid Foundation (to Y.Z.) and grants from the Canadian New Frontier Research Fund (NFRN-2019-00004) and 10.13039/501100000024CIHR (VR3_172632) (to L.F. [principal investigator], E.B. [coprincipal investigator], and N.F. [coprincipal investigator]). A.S.A. received a doctoral award from the Canadian Institutes of Health Research. E.D. and E.B. are, respectively, recipients of doctoral and senior awards from the Fonds de Recherche du Québec en Santé."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025